European Journal of Cancer · 2013 · 88 citations · 17 references
MedicineOncologyPharmacologyCancer PharmacologyCytotoxic ChemotherapyMalignant NeoplasmsOncogenic Signaling PathwaysTargeted Cancer TherapyGemcitabine-based TherapyMek InhibitionMek InhibitorsMek SignalingMitogen-activated Protein Kinase KinaseMitogen-activated Protein Kinase PathwaysProtein Kinase Inhibitors
17
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.9K citations
Medicine, Oncology, Pharmacology +17
Tumor-suppressive pathways in pancreatic carcinoma.
Ester Rozenblum, Mieke Schutte, Michael Goggins et al. · PubMed · 1997 · 699 citations